» Articles » PMID: 9231728

Effects of Ketone Bodies on Astrocyte Amino Acid Metabolism

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 1997 Aug 1
PMID 9231728
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of acetoacetate and 3-hydroxybutyrate on glial amino acid metabolism were studied in primary cultures of astrocytes. The exchange of nitrogen among amino acids was measured with 15N as a metabolic probe and gas chromatography-mass spectrometry as a tool with which to quantify isotope abundance. Addition of either acetoacetate or 3-hydroxybutyrate (5 mM) to the incubation medium did not alter the initial rate of appearance of [15N]glutamate in the glia, but it did inhibit transamination of glutamate to [15N]aspartate. Addition of acetoacetate also inhibited formation of [2-(15)N]glutamine, but 3-hydroxybutyrate had a stimulatory effect. The presence in the medium of sodium acetate (5 mM) was also associated with diminished production of [15N]aspartate and [2-(15)N]glutamine with [15N]glutamate as precursor. Studies with [2-(15)N]glutamine as precursor indicated that treatment of the astrocytes with ketone bodies did not alter flux through the glutaminase pathway. Nor did the presence of the ketone bodies reduce significantly the flux of nitrogen from [15N]GABA to [2-(15)N]glutamine when the former species served as a metabolic tracer. The concentration of internal citrate increased in the presence of acetoacetate, 3-hydroxybutyrate, and acetate. Studies with purified sheep brain glutamine synthetase showed that citrate inhibited this enzyme. These findings are considered in terms of the known anticonvulsant effect of a ketogenic diet.

Citing Articles

Ketogenic Diet as a Nutritional Metabolic Intervention for Obsessive-Compulsive Disorder: A Narrative Review.

Lounici A, Iacob A, Hongler K, Molling M, Drechsler M, Hersberger L Nutrients. 2025; 17(1.

PMID: 39796465 PMC: 11723184. DOI: 10.3390/nu17010031.


Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease.

Ramezani M, Fernando M, Eslick S, Asih P, Shadfar S, Bandara E Front Neurosci. 2023; 17:1297984.

PMID: 38033541 PMC: 10687427. DOI: 10.3389/fnins.2023.1297984.


The Evolution of Ketosis: Potential Impact on Clinical Conditions.

Dilliraj L, Schiuma G, Lara D, Strazzabosco G, Clement J, Giovannini P Nutrients. 2022; 14(17).

PMID: 36079870 PMC: 9459968. DOI: 10.3390/nu14173613.


Ketogenic diet, neuroprotection, and antiepileptogenesis.

Murugan M, Boison D Epilepsy Res. 2020; 167:106444.

PMID: 32854046 PMC: 7655615. DOI: 10.1016/j.eplepsyres.2020.106444.


Ketogenic and anaplerotic dietary modifications ameliorate seizure activity in Drosophila models of mitochondrial encephalomyopathy and glycolytic enzymopathy.

Fogle K, Smith A, Satterfield S, Gutierrez A, Hertzler J, McCardell C Mol Genet Metab. 2019; 126(4):439-447.

PMID: 30683556 PMC: 6536302. DOI: 10.1016/j.ymgme.2019.01.008.